Are you feeling fatigued, struggling with brain fog, or looking to optimize your health and longevity? In this episode of the Rare Wellness Podcast, co-host Nathalia and Dr. Jamie Lewis dive into the science of NAD+ (Nicotinamide Adenine Dinucleotide)—a critical molecule for energy production, cellular repair, and anti-aging.

As we age, our NAD+ levels decline, leading to reduced energy, slower recovery, and increased risk of chronic diseases. But what if you could restore these levels? NAD+ therapy—administered through IV infusions or injections—has been shown to enhance mental clarity, fight fatigue, improve metabolism, and support longevity.

🎙 In This Episode, You’ll Learn:

✅ What NAD+ is and why it’s essential for your body

✅ How NAD+ impacts energy, brain function, and aging

✅ The best ways to replenish NAD+ levels

✅ Who can benefit most from NAD+ therapy

✅ The long-term benefits of cellular repair and longevity

If you’re curious about cutting-edge regenerative medicine, this episode is for you!

🔗 Learn More & Book an NAD+ Infusion: www.nwc4rm.com and www.rarewellness.com

📌 Enjoying the Podcast?

👍 Like this video

📩 Share it with a friend

🔔 Subscribe for more bite-sized wellness insights

Peptides are emerging as powerful tools in regenerative medicine, offering potential benefits for healing, recovery, and performance optimization. These compounds are being studied for their ability to:

✅ Accelerate tissue repair – Enhancing healing for muscles, tendons, ligaments, and joints

✅ Reduce inflammation – Modulating immune responses to support faster recovery

✅ Protect gut health – Strengthening the GI lining and improving digestive function

✅ Support nerve regeneration – Promoting cognitive and neurological health

✅ Enhance athletic performance – Reducing oxidative stress and muscle fatigue

Dr. Jamie Lewis explores how these peptides work, the latest research, and key considerations for those looking to improve their overall health and recovery.

🔗 Learn more about regenerative medicine at: www.nwc4rm.com and www.rarewellness.com

📢 Enjoyed this episode? Don’t forget to like, comment, and subscribe to stay updated on the latest in health and longevity!

Works Cited:

1.  Current Pharmaceutical Design, 2020. “BPC-157 and Its Role in Healing.”

2.  Inflammation Research, 2019. “Anti-inflammatory Effects of BPC-157 in Experimental Models.”

3.  Cartilage, 2022. “Pentadecapeptides for Joint Repair.”

4.  Brain Research Bulletin, 2020. “Nerve Regeneration with BPC-157.”

5.  Free Radical Biology & Medicine, 2021. “Pentadecapeptides and Mitochondrial Health.”

GLP-1 receptor agonists like semaglutide and tirzepatide are transforming the fields of regenerative medicine, longevity, and performance health—but they’re not just for weight loss. In this episode of the Rare Wellness Podcast, Dr. Jamie Lewis breaks down how these powerful peptides work, their surprising benefits beyond metabolic health, and their role in reducing inflammation, enhancing cognitive function, supporting pain management, and even improving recovery and healing.

🔹 How GLP-1 RAs work to regulate blood sugar & metabolism

🔹 The unexpected benefits for cognitive health & neuroprotection

🔹 How these medications help with pain relief & inflammation

🔹 Why GLP-1s are a game changer for longevity & vitality

If you're curious about these cutting-edge treatments and how they can optimize your health, this episode is for you!

💡 Learn more about Dr. Jamie Lewis & book a consultation at: www.nwc4rm.com and www.rarewellness.com

👍 If you found this episode valuable, please like, subscribe, and share to support our mission of making wellness accessible to all.

Works Cited:

Wilding, J. P., et al. (2021). "Once-Weekly Semaglutide in Adults with Overweight or Obesity." The New England Journal of Medicine.

Jastreboff, A. M., et al. (2022). "Tirzepatide Once Weekly for the Treatment of Obesity." The New England Journal of Medicine.

Davies, M., et al. (2022). "Semaglutide 2.4 mg in Adults with Obesity or Overweight: Effects on Weight Loss and Maintenance." The Lancet.

Wadden, T. A., et al. (2022). "Weight Regain After Discontinuation of GLP-1 Receptor Agonists." Obesity Reviews.

Drucker, D. J. (2018). "Mechanisms of Action and Therapeutic Applications of GLP-1 Agonists in Inflammation and Neuroprotection." Cell Metabolism.

Holst, J. J., et al. (2020). "GLP-1 and its Role in Modulating Immune Function and Inflammation." Diabetes Care.

Ashina, M., et al. (2021). "GLP-1 Agonists in the Modulation of Pain Hypersensitivity: Implications for Migraine Management." The Journal of Headache and Pain.

Healthline. (2022). "Ozempic for Severe Osteoarthritis Knee Pain." Retrieved from healthline.com.

"Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent." Frontiers in Immunology, 2023. Retrieved from frontiersin.org.

"Beyond Glycemic Control: Exploring GLP-1 Agonists for Diabetic Foot Ulcer Healing." Diabetic Foot Online, 2024. Retrieved from diabeticfootonline.com.

"GLP-1 drugs linked to fewer post-surgical complications in diabetic patients." News-Medical, 2025. Retrieved from news-medical.net